Laurion Capital Management »

ResMed shares owned by Laurion Capital Management

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 5.7k 191.42
2021-06-30 $205k 833 246.10
2016-12-31 $453k 7.3k 62.05
2015-12-31 $354k 6.6k 53.64

More positions owned by Laurion Capital Management

NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Meta Platforms Cl A Call Option (META)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
United States Steel Corporation (X)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Hess (HES)
Ansys (ANSS)
Discover Financial Services (DFS)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Broadcom Call Option (AVGO)
Bridgebio Pharma (BBIO)
Bank of America Corporation (BAC)

View all positions for Laurion Capital Management

Top funds holding ResMed

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
Goldman Sachs Group
Select Equity
Charles Schwab Investment Management
Greenvale Capital
Dimensional Fund Advisors
Jpmorgan Chase & Co

View all funds holding ResMed